Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-06-11 to 2025-06-12
Current total value of award: $1903.92
Description: 4568513492!KONVOMEP 2-84 MG/ML ORAL SUSP 300ML